Literature DB >> 6619294

Proposed zone standards for interpretation of fortimicin A disk diffusion tests.

A L Barry, C Thornsberry, R N Jones.   

Abstract

Fortimicin A microdilution tests and disk diffusion tests (10-, 30-, and 50-micrograms disks) were performed with 454 selected bacterial strains. Tests with 30-micrograms disks were preferred, with zone standards of less than or equal to 14 mm of resistant strains (minimal inhibitory concentration, greater than 16 micrograms/ml) and greater than or equal to 17 mm for susceptible strains (minimal inhibitory concentration, less than 16 micrograms/ml).

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6619294      PMCID： PMC270824          DOI： 10.1128/jcm.18.2.440-442.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins.

Authors:  T Nara; M Yamamoto; I Kawamoto; K Takayama; R Okachi; S Takasawa; T Sato; S Sato
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

2.  Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification.

Authors:  R S Egan; R S Stanaszek; M Cirovic; S L Mueller; J Tadanier; J R Martin; P Collum; A W Goldstein; R L De Vault; A C Sinclair; E E Fager; L A Mitscher
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

3.  Enzymatic acetylation of fortimicin A and seldomycin factor 5 by aminoglycoside 3-acetyltransferase I: [AAC(3)-I] of E. coli KY8348.

Authors:  S Sato; T Iida; R Okachi; K Shirahata; T Nara
Journal:  J Antibiot (Tokyo)       Date:  1977-11       Impact factor: 2.649

4.  Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.

Authors:  J A Washington; P K Yu; T L Gavan; F D Schoenknecht; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.

Authors:  R L Girolami; J M Stamm
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

7.  Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

Authors:  R N Jones; A L Barry; P C Fuchs; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

Authors:  R N Jones; C Thornsberry; A L Barry; R R Packer; C N Baker; R E Badal
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

10.  Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948
  10 in total
  1 in total

1.  3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.

Authors:  A L Barry; R N Jones; C Thornsberry; T L Gavan; E H Gerlach; H M Sommer
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.